Considerations in Cannabis-Based Treatment
Cannabis has multiple pharmacologically active components capable of producing a wide range of clinical effects in humans. With growing evidence of the potential therapeutic benefits of cannabis, healthcare professionals must carefully consider all aspects of cannabis-based treatment, including formulation factors and potential interactions.
- Pharmacy Technicians
- Discuss the endocannabinoid system, cannabinoid pharmacology, cannabinoid products, and common formulations.
- Apply information from the medical literature to specific patient case scenarios for the safe therapeutic use of medical cannabis.
- Design a role for the pharmacist related to medical cannabis for patient counseling in various settings.
- Develop a plan for the pharmacist when patients report medical cannabis use and their desire to continue therapy across transitions of care.
- Discuss the endocannabinoid system, cannabinoid pharmacology, and cannabinoid products.
- Review different formulations and dosage forms commonly applied in cannabis therapy.
- Evaluate important safety considerations for medical cannabis use.
- Recognize important information to communicate to the patients receiving cannabis therapy.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
The activity is copyright © 2018 LP3 Network.
Christine Roussel, PharmD, BCOP
Christine Roussel is a board certified oncology pharmacist and the Assistant Director of Pharmacy at Doylestown Hospital in Pennsylvania where she is responsible for clinical program development and compounding activities. Dr. Roussel also serves as adjunct professor at the University of the Sciences in Philadelphia. Dr. Roussel is an expert in hazardous compounding and has served as the Cancer Center Pharmacy Manager at the Einstein Healthcare System where she was instrumental in directing the design and clinical workflow processes and protocols for the dedicated on-site oncology pharmacy facility. As well, she managed the planning, building and maintenance of the sterile hazardous drug compounding facility. Dr. Roussel also established an outpatient specialty pharmacy service line for cancer center patients, providing clinical and copay-assistance guidance to patients. In her previous role as the Vice President of Pharmacy Operations for the OncoMed Oncology Pharmacy of Philadelphia, a closed door specialty pharmacy, Dr. Roussel oversaw training of all clinical staff on treatment guidelines, patient counseling, regulatory requirements, compounding techniques, and the safe handling of hazardous chemotherapy agents. Dr. Roussel oversaw the maintenance of the cleanroom facilities and wrote the company’s policies and procedures for their sterile compounding program.
Dr. Roussel received her Bachelor of Science in Toxicology and her Doctorate in Pharmacy from the Philadelphia College of Pharmacy at the University of the Sciences and is currently an active member of the American Society of Health System Pharmacists (ASHP), the American Pharmacist Association (APhA), and the Hematology Oncology Pharmacists Association (HOPA). Dr. Roussel is also an active member of the Legislative Action Committee for the Pennsylvania Society of Health Systems Pharmacy.
This program is accredited by the Accreditation Council for Pharmacy Education (ACPE) through CPE Consultants, LLC.
Total CPE Credits: 1.5 CPE Hour = 0.15 CEU
Pharmacy Technician UAN
1.5 CPE Hour = 0.15 CEU
October 27th 2018
October 27th 2019
|CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|